Literature DB >> 18674973

Liquid chromatography-tandem mass spectrometric assay for diclofenac and three primary metabolites in mouse plasma.

Rolf W Sparidans1, Jurjen S Lagas, Afred H Schinkel, Jan H M Schellens, Jos H Beijnen.   

Abstract

The first liquid chromatography-tandem mass spectrometric assay for the simultaneous determination of diclofenac, 4'-hydroxy-diclofenac, 5-hydroxy-diclofenac and diclofenac-acyl-glucuronide in mouse plasma, using a simple sample pre-treatment procedure, was developed and validated. Analytes in plasma were stabilized using acetic acid and ascorbic acid. After addition of the internal standard D(4)-diclofenac to a 10 microl sample volume and protein precipitation with acetonitrile, the supernatant was supplemented with an equal volume of water and injected into the chromatographic system. A polar embedded reversed-phase column with gradient elution using formic acid and ammonium acetate in water-methanol were used. The eluate was totally transferred into an electrospray interface with positive ionization and the analytes were quantified using triple quadrupole mass spectrometry. The assay was validated in the ranges 10-5000 ng/ml for 4'-hydroxy-diclofenac and 20-10,000 ng/ml for the other analytes, the lowest levels of these ranges (10 or 20 ng/ml) being the lower limits of quantification. Within day precisions were < or = 10%, between day precisions < or = 13% and accuracies were between 90 and 108%. The analytes were chemically stable under all relevant conditions. The assay was successfully applied in a pharmacokinetic study with diclofenac in mice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18674973     DOI: 10.1016/j.jchromb.2008.07.012

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  7 in total

1.  Development of an ultra fast online-solid phase extraction (SPE) liquid chromatography electrospray tandem mass spectrometry (LC-ESI-MS/MS) based approach for the determination of drugs in pharmacokinetic studies.

Authors:  Nils Helge Schebb; Bora Inceoglu; Tristan Rose; Karen Wagner; Bruce D Hammock
Journal:  Anal Methods       Date:  2011-01-01       Impact factor: 2.896

2.  Mass spectrometric characterization of circulating covalent protein adducts derived from a drug acyl glucuronide metabolite: multiple albumin adductions in diclofenac patients.

Authors:  Thomas G Hammond; Xiaoli Meng; Rosalind E Jenkins; James L Maggs; Anahi Santoyo Castelazo; Sophie L Regan; Stuart N L Bennett; Caroline J Earnshaw; Guruprasad P Aithal; Ira Pande; J Gerry Kenna; Andrew V Stachulski; B Kevin Park; Dominic P Williams
Journal:  J Pharmacol Exp Ther       Date:  2014-06-05       Impact factor: 4.030

3.  Role of intestinal cytochrome p450 enzymes in diclofenac-induced toxicity in the small intestine.

Authors:  Yi Zhu; Qing-Yu Zhang
Journal:  J Pharmacol Exp Ther       Date:  2012-08-14       Impact factor: 4.030

4.  A pharmacokinetic evaluation and metabolite identification of the GHB receptor antagonist NCS-382 in mouse informs novel therapeutic strategies for the treatment of GHB intoxication.

Authors:  Garrett R Ainslie; K Michael Gibson; Kara R Vogel
Journal:  Pharmacol Res Perspect       Date:  2016-10-18

5.  Diclofenac Concentrations in Post-Mortem Specimens-Distribution, Case Reports, and Validated Method (UHPLC-QqQ-MS/MS) for Its Determination.

Authors:  Paweł Szpot; Olga Wachełko; Marcin Zawadzki
Journal:  Toxics       Date:  2022-07-26

6.  Square Wave Voltammetric Determination of Diclofenac in Pharmaceutical Preparations and Human Serum.

Authors:  Ulvihan Ciltas; Bilal Yilmaz; Selcuk Kaban; Bilge Kaan Akcay; Gulsah Nazik
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

7.  Validated Stability-Indicating HPLC-DAD Method for the Simultaneous Determination of Diclofenac Sodium and Diflunisal in Their Combined Dosage Form.

Authors:  Rasha A Shaalan; Tarek S Belal
Journal:  Sci Pharm       Date:  2013-03-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.